Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior.


Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
28 Jun 2024
Historique:
received: 25 03 2024
accepted: 09 06 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses. Using structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists. Although in vitro potency (EC Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.

Sections du résumé

BACKGROUND BACKGROUND
Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses.
METHODS METHODS
Using structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists.
RESULTS RESULTS
Although in vitro potency (EC
CONCLUSIONS CONCLUSIONS
Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.

Identifiants

pubmed: 38937807
doi: 10.1186/s13071-024-06347-w
pii: 10.1186/s13071-024-06347-w
doi:

Substances chimiques

Receptors, Neuropeptide Y 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

276

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM137888
Pays : United States
Organisme : The Arnold and Mabel Beckman Foundation
ID : Beckman Young Investigator Award
Organisme : The Pew Foundation
ID : Pew Biomedical Scholars Award
Organisme : Esther A. and Joseph Klingenstein Fund
ID : Klingenstein-Simons Fellowship Award in Neuroscience

Informations de copyright

© 2024. The Author(s).

Références

Judson CL. Feeding and oviposition behavior in the mosquito Aedes aegypti (L.). I. Preliminary studies of physiological control mechanisms. Biol Bull. 1967;133:369–77.
pubmed: 6062263
Duvall LB, Ramos-Espiritu L, Barsoum KE, Glickman JF, Vosshall LB. Small-molecule agonists of Ae. aegypti neuropeptide Y receptor block mosquito biting. Cell. 2019;176:687–701.
pubmed: 30735632 pmcid: 6369589
Klowden MJ, Lea AO. Abdominal distention terminates subsequent host-seeking behaviour of Aedes aegypti following a blood meal. J Insect Physiol. 1979;25:583–5.
pubmed: 544697
Galun R. Feeding response in Aedes aegypti: stimulation by adenosine triphosphate. Science. 1963;142:1674–5.
Brown MR, Klowden MJ, Crim JW, Young L, Shrouder LA, Lea AO. Endogenous regulation of mosquito host-seeking behavior by a neuropeptide. J Insect Physiol. 1994;40:399–406.
Davis EE. Regulation of sensitivity in the peripheral chemoreceptor systems for host-seeking behavior by a haemolymph-borne factor in Aedes aegypti. J Insect Physiol. 1984;30:179–83.
Klowden MJ, Lea A. Humoral inhibition of host seeking in Aedes aegypti during oocyte maturation. 1979;25.
Klowden MJ. Initiation and termination of host-seeking. 1981;27:799–803.
Liesch J, Bellani LL, Vosshall LB. Functional and genetic characterization of Neuropeptide Y-Like receptors in Aedes aegypti. PLoS Negl Trop Dis. 2013;7:e2486.
pubmed: 24130914 pmcid: 3794971
Christ P, Hill SR, Schachtner J, Hauser F, Ignell R. Functional characterization of mosquito short neuropeptide F receptors. Peptides. 2018;103:31–9.
pubmed: 29550617
Colmers WF, Wahlestedt C. The biology of neuropeptide Y and related peptides. Springer Science & Business Media; 1993.
Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides--mediation of the actions of leptin. Trends Neurosci. 1999;22:62–7.
pubmed: 10092045
De Bono M, Bargmann CI. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell. 1998;94:679–89.
pubmed: 9741632
Wu Q, Wen T, Lee G, Park JH, Cai HN, Shen P. Developmental control of foraging and social behavior by the Drosophila neuropeptide Y-like system. Neuron. 2003;39:147–61.
pubmed: 12848939
Kuenzel WJ, Douglass LW, Davison BA. Robust feeding following central administration of neuropeptide Y or peptide YY in chicks, Gallus domesticus. Peptides. 1987;8:823–8.
pubmed: 3432131
Abel R, Wang L, Harder ED, Berne BJ, Friesner RA. Advancing drug discovery through enhanced free energy calculations. Acc Chem Res. 2017;50:1625–32.
pubmed: 28677954
Zhang J, Yang J, Jang R, Zhang Y. GPCR-I-TASSER: a hybrid approach to G protein-coupled receptor structure modeling and the application to the human genome. Structure. 2015;23:1538–49.
pubmed: 26190572 pmcid: 4526412
Harder E, Damm W, Maple J, Wu C, Reboul M, Xiang JY, et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput. 2016;12:281.
pubmed: 26584231
Khalak Y, Tresadern G, Aldeghi M, Baumann HM, Mobley DL, de Groot BL, et al. Alchemical absolute protein-ligand binding free energies for drug design. Chem Sci. 2021;12:13958–71.
pubmed: 34760182 pmcid: 8549785
Costa-da-Silva AL, Navarrete FR, Salvador FS, Karina-Costa M, Ioshino RS, Azevedo DS, et al. Glytube: a conical tube and Parafilm M-based method as a simplified device to artificially blood-feed the dengue vector mosquito, Aedes aegypti. PLoS ONE. 2013;8:e53816.
pubmed: 23342010 pmcid: 3544740
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504–7.
pubmed: 23563266 pmcid: 3651993
Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G, et al. Zika virus: history, emergence, biology, and prospects for control. PLoS ONE. 2013;13:1–15.
Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 2015;
Ryan SJ, Carlson CJ, Mordecai EA, Johnson LR. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change. PLoS Negl Trop Dis. 2019;13:1–20.
Adams LE, Waterman S, Paz-Bailey G. Vaccination for dengue prevention. JAMA. 2021;327:817–8.
Moyes CL, Vontas J, Martins AJ, Ng LC, Koou SY, Dusfour I, et al. Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans. PLoS Negl Trop Dis. 2021;15:1–2.
Blumberg BJ, Short SM, Dimopoulos G. Employing the Mosquito Microflora for Disease Control. Genetic control of malaria and dengue. Elsevier Inc.; 2016. 335–362.
Lees RS, Gilles JR, Hendrichs J, Vreysen MJ, Bourtzis K. Back to the future: the sterile insect technique against mosquito disease vectors. Curr Opin Insect Sci. 2015;10:156–62.
pubmed: 29588003
Parihar K, Telang M, Ovhal A. A patent review on strategies for biological control of mosquito vector. World J Microbiol Biotechnol. 2020;36:1–23.
Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C, Katsanos D, et al. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol. 2016;34:78–83.
pubmed: 26641531
Macias VM, Ohm JR, Rasgon JL. Gene drive for mosquito control: where did it come from and where are we headed? Int J Environ Res Public Health. 2017;14:1006.
pubmed: 28869513 pmcid: 5615543
González-Morales MA, Thomson AE, Yeatts J, Enomoto H, Haija A, Santangelo RG, et al. Pharmacokinetics of fluralaner as a systemic drug to control infestations of the common bed bug, Cimex lectularius, in poultry facilities. Parasit Vectors. 2023;16:1–8.
Qiu H, Jun HW, Tao J. Pharmacokinetics of insect repellent N,N-diethyl-m-toluamide in beagle dogs following intravenous and topical routes of administration. J Pharm Sci. 1997;86:514–6.
pubmed: 9109058
Liu N. Insecticide resistance in mosquitoes: impact, mechanisms, and research directions. Annu Rev Entomol. 2015;60:537–59.
pubmed: 25564745
Su X, Guo Y, Deng J, Xu J, Zhou G, Zhou T, et al. Fast emerging insecticide resistance in Aedes albopictus in Guangzhou, China: alarm to the dengue epidemic. PLoS Negl Trop Dis. 2019;13:1–15.
World Health Organization. Global plan for insecticide resistance management in malaria vectors. Geneva: Switzerland; 2012.
Witmer GW, Raymond-Whish S, Moulton RS, Pyzyna BR, Calloway EM, Dyer CA, et al. Compromised fertility in free feeding of wild-caught Norway rats (Rattus norvegicus) with a liquid bait containing 4-Vinylcyclohexene diepoxide and triptolide. J Zoo Wildl Med. 2017;48:80–90.
pubmed: 28363061
Savino F, Ricciardi R, Iodice A, Benelli G, Conte G, Lucchi A, et al. Eco-friendly pheromone dispensers—a green route to manage the European grapevine moth? Environ Sci Pollut Res. 2018;25:9426–42.
Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K. Silkworm as a model animal to evaluate drug candidate toxicity and metabolism. Comp Biochem Physiol C Toxicol Pharmacol. 2009;149:334–9.
pubmed: 18804554
He Y, Xu X, Qiu J, Yin W, Sima Y, Xu S. Bombyx mori used as a fast detection model of liver melanization after a clinical drug–acetaminophen exposure. J Asia Pac Entomol. 2020;23:177–85.
Duthaler U, Weber M, Hofer L, Chaccour C, Maia M, Müller P, et al. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes. PLoS Pathog. 2021;17:1–18.
Gulia-Nuss M, Nuss AB, Meyer JM, Sonenshine DE, Roe RM, Waterhouse RM, et al. Genomic insights into the Ixodes scapularis tick vector of Lyme disease. Nat Commun. 2016;7.
Garczynski SF, Crim JW, Brown MR. Characterization of neuropeptide F and its receptor from the African malaria mosquito, Anopheles gambiae. Peptides. 2005;26:99–107.
pubmed: 15626509
Fiorenzano JM, Koehler PG, Xue RD. Attractive toxic sugar bait (ATSB) for control of mosquitoes and its impact on non-target organisms: a review. Int J Environ Res Public Health. 2017;14:398.
pubmed: 28394284 pmcid: 5409599
Krockel U, Rose A, Eiras AE, Geier M. New tools for surveillance of adult yellow fever mosquitoes: comparison of trap catches with human landing rates in an urban environment. J Am Mosq Control Assoc. 2006;22:229–38.
pubmed: 17019768
Mukabana WR, Mweresa CK, Otieno B, Omusula P, Smallegange RC, van Loon JJA, et al. A novel synthetic odorant blend for trapping of malaria and other African mosquito species. J Chem Ecol. 2012;38:235–44.
pubmed: 22426893 pmcid: 3310138
Okumu FO, Killeen GF, Ogoma S, Biswaro L, Smallegange RC, Mbeyela E, et al. Development and field evaluation of a synthetic mosquito lure that is more attractive than humans. PLoS ONE. 2010;5:8951.
Suparit P, Wiratsudakul A, Modchang C. A mathematical model for Zika virus transmission dynamics with a time-dependent mosquito biting rate. Theor Biol Med Model. 2018;15:1–11.

Auteurs

Emely V Zeledon (EV)

Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY, 10065, USA.
Howard Hughes Medical Institute, New York, NY, 10065, USA.

Leigh A Baxt (LA)

Sanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.

Tanweer A Khan (TA)

Sanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Atai Life Sciences, New York, NY, 10012, USA.

Mayako Michino (M)

Sanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.

Michael Miller (M)

Sanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.

David J Huggins (DJ)

Sanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, 10065, USA.

Caroline S Jiang (CS)

Center for Clinical and Translational Science, The Rockefeller University, New York, NY, 10065, USA.

Leslie B Vosshall (LB)

Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY, 10065, USA.
Howard Hughes Medical Institute, New York, NY, 10065, USA.
Kavli Neural Systems Institute, New York, NY, 10065, USA.

Laura B Duvall (LB)

Department of Biological Sciences, Columbia University, New York, NY, 10027, USA. lbd2126@columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH